NervGen Pharma Corp. (NGEN)
1.78
+0.02
(+1.14%)
USD |
NASDAQ |
Oct 02, 16:00
1.82
+0.04
(+2.25%)
After-Hours: 20:00
NervGen Pharma Market Cap : 189.41M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 189.41M |
| October 01, 2026 | 187.29M |
| September 30, 2026 | 203.25M |
| September 29, 2026 | 204.31M |
| September 28, 2026 | 200.06M |
| September 25, 2026 | 206.44M |
| September 24, 2026 | 214.95M |
| September 23, 2026 | 208.57M |
| September 22, 2026 | 219.74M |
| September 21, 2026 | 211.76M |
| September 18, 2026 | 218.15M |
| September 17, 2026 | 241.56M |
| September 16, 2026 | 226.66M |
| September 15, 2026 | 227.72M |
| September 14, 2026 | 233.58M |
| September 11, 2026 | 232.51M |
| September 10, 2026 | 229.85M |
| September 09, 2026 | 226.66M |
| September 08, 2026 | 233.04M |
| September 04, 2026 | 247.94M |
| September 03, 2026 | 246.88M |
| September 02, 2026 | 247.94M |
| September 01, 2026 | 246.88M |
| August 31, 2026 | 235.17M |
| August 28, 2026 | 242.62M |
| Date | Value |
|---|---|
| August 27, 2026 | 248.47M |
| August 26, 2026 | 235.17M |
| August 25, 2026 | 221.34M |
| August 24, 2026 | 212.83M |
| August 21, 2026 | 197.93M |
| August 20, 2026 | 187.29M |
| August 19, 2026 | 186.22M |
| August 18, 2026 | 181.97M |
| August 17, 2026 | 178.77M |
| August 14, 2026 | 184.63M |
| August 13, 2026 | 187.29M |
| August 12, 2026 | 187.29M |
| August 11, 2026 | 185.16M |
| August 10, 2026 | 137.68M |
| August 07, 2026 | 138.49M |
| August 06, 2026 | 139.30M |
| August 05, 2026 | 136.06M |
| August 04, 2026 | 134.44M |
| August 03, 2026 | 132.83M |
| July 31, 2026 | 131.21M |
| July 30, 2026 | 129.59M |
| July 29, 2026 | 128.78M |
| July 28, 2026 | 130.40M |
| July 27, 2026 | 132.83M |
| July 24, 2026 | 132.02M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 7.101M |
| Milestone Pharmaceuticals, Inc. | 100.81M |
| Clearmind Medicine, Inc. | 1.534M |
| Lexaria Bioscience Corp. | 4.759M |
| Target Group, Inc. (Canada) | 0.4319M |
Market Cap Related Metrics
| PEG Ratio | -0.0345 |
| Price to Book Value | 15.55 |
| Price | 1.78 |
| Earnings Yield | -30.11% |
| PEGY Ratio | -0.0345 |